[Skip to Content]
[Skip to Content Landing]
Comment & Response
November 12, 2014

Erythropoietin for Traumatic Brain Injury

Author Affiliations
  • 1Department of Critical Care Medicine, University College Dublin, Dublin, Ireland
  • 2Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
  • 3Department of Intensive Care, Western Health, Victoria, Australia
JAMA. 2014;312(18):1928-1929. doi:10.1001/jama.2014.12738

To the Editor Dr Robertson and colleagues1 conducted a 2 × 2 factorial design randomized clinical trial of 200 patients with traumatic brain injury to test the effect of 2 approaches to transfusion threshold and erythropoietin therapy on neurological outcome. Unfortunately, their findings that erythropoietin failed to demonstrate an outcome benefit reflect substantial lack of statistical power.

First Page Preview View Large
First page PDF preview
First page PDF preview